The single-use bioprocessing systems market is extremely competitive as the top five players accounted for a combined share of 95.2% share in 2015, finds Transparency Market Research (TMR). The top companies are Thermo Fisher Scientific, GE Healthcare, Pall Corporation, Merck KGaA, and Sartorius AG. The mammoth share held by large global biotechnology and pharmaceutical companies indicates that the threat of new entrants is moderate. Leading companies in the single-use bioprocessing systems market offer unique proprietary products leading to high barrier to entry, notes TMR. However over the forecast period, with the entry of several new players, the degree of competition in the market is projected to remain moderate-to-high.
The global single-use bioprocessing systems market was valued at US$2.3 bn in 2015. Rising at a CAGR of 11.1% from 2016 to 2024, the market is expected to reach US$5.9 bn by the end of the forecast period.
Asia Pacific Market to Provide Lucrative Growth Avenues
Geographically, Europe occupied the major share in 2016 and is projected to dominate the global single-use bioprocessing systems market through the forecast period. However, this regional market is likely to lose some of its share in the coming years. Meanwhile, the Asia Pacific market for single-use bioprocessing systems is anticipated to emerge as one of the most lucrative regional markets, expanding at 12.3% CAGR during 2016–2024.
On the basis of product, the single-use bioprocessing bags segment is expected to dominate the market and is projected to attain a significant share of 27.0% share by the end of 2024. The substantial growth of the bioprocessing bags segment can be attributed to their substantial demand for a variety of upstream and downstream applications. Bioprocessing bags are extensively used in processes such as mixing, storage, filtration, media preparation, and fermentation during the production of drug molecules, monoclonal antibodies, and vaccines.
Customization in Single-Use Bioprocessing Systems to Bolster Uptake
The growth of the single-use bioprocessing systems market is propelled by a wide gamut of biotechnological applications such as monoclonal antibody production, plant cell cultivation, patient specific cell therapies, and vaccine production. The surge in production of monoclonal antibodies in developed regions has translated for a substantial demand for single-use bioprocessing systems. Favorable regulations by various agencies such as the U.S. Food and Drug Administration (FDA) and extensive support from the European Union (EU) to boost the production of antibody therapeutics have catalyzed the growth of the single-use bioprocessing systems market.
The rising demand for customization in single-use bioprocessing systems is a crucial factor fueling the market growth. Increase in number of customer-specific customization requests tailored to specific needs has positively impacted the single-use bioprocessing systems market. Furthermore, the growing adoption of single-use bioprocessing technologies by several contract research organizations (CROs) is expected to boost the market through the forecast period.
However, technical constraints and several environmental concerns related to disposable of bags are key factors likely to hinder the market to an extent. Nevertheless, constant technological advancements in bioprocessing has led to innovative products that are cost-effective and significantly reduce product cross-contamination in various manufacturing processes. The elimination of clean-in-place (CIP) methods in many pharmaceutical plants has further catapulted the demand for single-use bioprocessing systems. This is expected to create exciting growth opportunities for market players.
The study presented here is based on a report by Transparency Market Research (TMR) titled, “Single-use Bioprocessing Systems Market - (Product - Bioreactors and Fermenters, Mixers, Bags, Bioprocess Containers, Filtration Devices, Tubing, Sampling Systems, Connectors and Clamps, and Probes and Sensors; End User - Pharmaceutical, Biotechnology, CRO and CMO, and Academic and Research Institutes; Application - Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, and Production of Enzymes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The single-use bioprocessing systems market is segmented based on:
- Bioreactors & Fermenters
- Bioprocess Containers
- Filtration Devices
- Sampling Systems
- Connectors & Clamps
- Probes & Sensors
- CRO & CMO
- Academic & Research Institutes
- Monoclonal Antibody Production
- Vaccine Production
- Plant Cell Cultivation
- Patient Specific Cell Therapies
- Production of Enzymes
- North America
- Asia Pacific
- Australia & New Zealand
- Rest of APAC
- Rest of Europe
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC